Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
60M
-
Number of holders
-
53
-
Total 13F shares, excl. options
-
21.9M
-
Shares change
-
-172K
-
Total reported value, excl. options
-
$71.6M
-
Value change
-
-$640K
-
Put/Call ratio
-
0.47
-
Number of buys
-
19
-
Number of sells
-
-36
-
Price
-
$3.27
Significant Holders of Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share (ALDX) as of Q1 2024
72 filings reported holding ALDX - Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share as of Q1 2024.
Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share (ALDX) has 53 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 21.9M shares
of 60M outstanding shares and own 36.47% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (8.59M shares), Knoll Capital Management, LLC (5.48M shares), KENNEDY CAPITAL MANAGEMENT LLC (1.32M shares), Verition Fund Management LLC (940K shares), STATE STREET CORP (940K shares), D. E. Shaw & Co., Inc. (548K shares), BANK OF AMERICA CORP /DE/ (399K shares), NORTHERN TRUST CORP (389K shares), MILLENNIUM MANAGEMENT LLC (389K shares), and TWO SIGMA ADVISERS, LP (375K shares).
This table shows the top 53 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.